Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact

被引:0
作者
Frank Gieseler
Hendrik Ungefroren
Utz Settmacher
Morley D Hollenberg
Roland Kaufmann
机构
[1] University Hospital Schleswig-Holstein (UKSH) Campus Lübeck,First Department of Medicine
[2] Jena University Hospital,Department of General, Visceral and Vascular Surgery, Experimental Transplantation Surgery
[3] Department of Physiology & Pharmacology,undefined
[4] and Department of Medicine,undefined
[5] University of Calgary,undefined
[6] Faculty of Medicine,undefined
来源
Cell Communication and Signaling | / 11卷
关键词
Epidermal Growth Factor Receptor; Thrombin; Epidermal Growth Factor Receptor Activation; Epidermal Growth Factor Receptor Transactivation; PAR1 Antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
Proteinase-activated receptors (PARs) are a subfamily of G protein-coupled receptors (GPCRs) with four members, PAR1, PAR2, PAR3 and PAR4, playing critical functions in hemostasis, thrombosis, embryonic development, wound healing, inflammation and cancer progression. PARs are characterized by a unique activation mechanism involving receptor cleavage by different proteinases at specific sites within the extracellular amino-terminus and the exposure of amino-terminal “tethered ligand“ domains that bind to and activate the cleaved receptors. After activation, the PAR family members are able to stimulate complex intracellular signalling networks via classical G protein-mediated pathways and beta-arrestin signalling. In addition, different receptor crosstalk mechanisms critically contribute to a high diversity of PAR signal transduction and receptor-trafficking processes that result in multiple physiological effects.
引用
收藏
相关论文
共 1332 条
[1]  
Alexander SP(2008)Guide to receptors and channels (GRAC), 3rd edition Br J Pharmacol 153 S1-S209
[2]  
Mathie A(2002)International union of pharmacology. XXVIII. Proteinase-activated receptors Pharmacol Rev 54 203-217
[3]  
Peters JA(2004)Protease-activated receptors: contribution to physiology and disease Physiol Rev 84 579-621
[4]  
Hollenberg M(2008)Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more Br J Pharmacol 153 S263-S282
[5]  
Compton S(2005)Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response Endocr Rev 26 1-43
[6]  
Ossovskaya V(2011)Structure, function and pathophysiology of protease activated receptors Pharmacol Ther 130 248-282
[7]  
Bunnett N(2012)Targeting proteinase-activated receptors: therapeutic potential and challenges Nat Rev Drug Discov 11 69-86
[8]  
Ramachandran R(1999)Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J 18 1723-1729
[9]  
Hollenberg M(2005)Mammalian G proteins and their cell type specific functions Physiol Rev 85 1159-1204
[10]  
Steinhoff M(1991)Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 1057-1068